31 Other financial income/expense
millions of € |
|
|
|
|---|---|---|---|
|
2023 |
2022 |
2021 |
Income from investments (without share of profit (loss) of associates and joint ventures accounted for using the equity method) |
22 |
5 |
4 |
Gains (losses) from financial instruments |
170 |
784 |
(593) |
Interest component from measurement of provisions and liabilities |
(536) |
590 |
167 |
Impairment losses on other financial assets |
0 |
0 |
(13) |
Gains (losses) from the write-off of other financial assets measured at amortized cost |
0 |
0 |
0 |
|
(345) |
1,379 |
(435) |
Other financial income declined from EUR 1.4 billion to a financial expense of EUR 0.3 billion, in particular in connection with the interest component from the measurement of provisions and liabilities. This decrease was mainly attributable to the subsequent measurement using actuarial principles of the present value of the provision recognized for the Civil Service Health Insurance Fund. In the prior year, the measurement was affected by the significant increase in the interest rate level in that period. Gains from financial instruments decreased by EUR 0.6 billion to EUR 0.2 billion.
EUR 129 million (2022: EUR -226 million, 2021: EUR -282 million) of gains/losses from financial instruments related to currency translation effects, and EUR 41 million (2022: EUR 1,010 million, 2021: EUR -310 million) to gains/losses from other derivatives as well as measurements of equity investments.
As a rule, all income/expense components including interest income and expense from financial instruments classified as at fair value through profit or loss in accordance with IFRS 9 are reported under gains/losses from financial instruments.
For further information on financial instruments, please refer to Note 43 “Financial instruments and risk management.”